Concepedia

Author

R Serafino

Bristol-Myers Squibb (United States)

Also Known As

R Serafino, R. P. SERAFINO, R. Serafino, R.P. Serafino, Randolph P. Serafino, Randolph Serafino, Serafino, R.P.

12

Publications

255

Citations

6

H-Index

25

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Bristol-Myers Squibb (Sweden)
RS

About

R Serafino is an author at Bristol-Myers Squibb (United States) specializing in medicine, organic chemistry, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

121

2

Natural Sciences

2

2

34

3

Biochemistry

1

1

16

4

Cell Biology

1

1

87

5

Cellular Physiology

1

1

87

R Serafino

×

6

Publications

253

Citations

6

H-Index

YearCitations

Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms.

H. Wéber, Maria L. Webb, R Serafino,

Molecular Endocrinology

1994

87

Effects of thrombin and thrombin receptor activating peptides on rat aortic vascular smooth muscle.

Michael J. Antonaccio, Diane E. Normandin, R Serafino,

Journal of Pharmacology and Experimental Therapeutics

1993

55

BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist.

Marjorie Webb, J. Eileen Bird, Eddie C.‐K. Liu,

Journal of Pharmacology and Experimental Therapeutics

1995

41

BMS‐180560, an insurmountable inhibitor of angiotensin II‐stimulated responses: comparison with losartan and EXP3174

Kenneth E.J. Dickinson, Robert Cohen, S. Skwish,

British Journal of Pharmacology

1994

36

Design and Synthesis of 4-Substituted Benzamides as Potent, Selective, and Orally Bioavailable <i>I</i><sub>Ks</sub> Blockers

John Lloyd, Joan B. Schmidt, George C. Rovnyak,

Journal of Medicinal Chemistry

2001

18

Synthesis of N-Alkyl-1,2,4-oxadiazinones as Angiotensin-II (AT1) Receptor Antagonists

Harold N. Weller, Arthur V. Miller, Kenneth E.J. Dickinson,

Heterocycles

1993

16

Page 1